Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NYSE:BMR

Biomed Realty Trust (BMR) Stock Price, News & Analysis

Biomed Realty Trust logo

About Biomed Realty Trust Stock (NYSE:BMR)

Advanced Chart

Key Stats

Today's Range
$2.21
$2.40
50-Day Range
N/A
52-Week Range
$17.94
$25.08
Volume
78,104 shs
Average Volume
3.29 million shs
Market Capitalization
$30.91 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

BioMed Realty Trust, Inc. operates as a real estate investment trust (REIT). The Company is the parent company and general partner of BioMed Realty, L.P. The Company owns, acquires, develops, redevelops, leases and manages laboratory and office space for the life science industry. The Company's tenants primarily include biotechnology and pharmaceutical companies, scientific research institutions, government agencies and other entities involved in the life science industry. The Company's properties are located in markets, which has centers for scientific research, including Boston, San Francisco, San Diego, Maryland, New York, New Jersey, Pennsylvania, North Carolina, Seattle, Cambridge (the United Kingdom) and research parks located near or adjacent to universities and their related medical systems. The Company owns interests in properties comprising approximately 17.5 million rentable square feet.

Receive BMR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Biomed Realty Trust and its competitors with MarketBeat's FREE daily newsletter.

BMR Stock News Headlines

Biomed Realty Tr (BMR)
The Crypto Market is About to Change Lives
I've discovered something so significant about the 2025 crypto market that I had to put everything else aside and write a book about it. This isn't just another Bitcoin prediction – it's a complete roadmap for what I believe will be the biggest wealth-building opportunity of this decade. The evidence is so compelling, I'm doing something that probably seems insane: I'm giving away my entire book for free.
See More Headlines

BMR Stock Analysis - Frequently Asked Questions

Biomed Realty Trust Inc (NYSE:BMR) announced its quarterly earnings data on Tuesday, April, 28th. The real estate investment trust reported $0.41 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.37 by $0.04. The business's revenue for the quarter was up 5.4% on a year-over-year basis.

Biomed Realty Trust (BMR) raised $8 million in an initial public offering on Tuesday, February 28th 2023. The company issued 1,950,000 shares at a price of $4.00 per share.

Based on aggregate information from My MarketBeat watchlists, some other companies that Biomed Realty Trust investors own include NVIDIA (NVDA), Tesla (TSLA), Ford Motor (F), Meta Platforms (META), Broadcom (AVGO), Norwegian Cruise Line (NCLH) and NIO (NIO).

Company Calendar

Last Earnings
4/28/2015
Today
4/24/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Industry
Prepackaged software
Sub-Industry
Office REITs
Current Symbol
NYSE:BMR
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$2.91 million
Price / Cash Flow
N/A
Book Value
$0.80 per share
Price / Book
3.00

Miscellaneous

Free Float
N/A
Market Cap
$30.91 million
Optionable
Not Optionable
Beta
5.22
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

This page (NYSE:BMR) was last updated on 4/24/2025 by MarketBeat.com Staff
From Our Partners